At Kindeva, our global network of facilities is designed to fast-track healthier tomorrows. We invest in the highest quality technologies and analytical capabilities to provide strategic value that extends beyond manufacturing. With a cGMP footprint of nearly one million sq. ft., your product benefits from our unique combination of cutting-edge technology and high capacity, enabling us to manufacture more tomorrows for patients worldwide.
Our world-class facility in Bridgeton, Missouri, features over 155,000 sq. ft. (~14,400 m2) of dedicated aseptic operations space, including two state-of-the-art laboratories, formulation suites and almost 11,000 sq. ft. (~1,022 m2) of fill suites.
Maryland Heights is a 174,850 sq. ft. (16,244 m2) inspection, device assembly and packaging facility that manufactures finished autoinjector units.
Our 70,000 sq. ft. (6,500 m2) facility in Lexington, KY, houses our nasal spray operations, including development, manufacturing and analytical support capabilities.